Related Experiment Video

Updated: Nov 8, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

10.9K

Application of Nano-Insulin Pump in Children with Diabetic Ketoacidosis

Jiao Wang1, Lihai Zhang2, Xianhe Wang1

  • 1Department of Pediatrics, The First Affiliated Hospital of Jiamusi University, Jiamusi 154000, Heilongjiang, PR China.

Journal of Nanoscience and Nanotechnology
|April 20, 2021
PubMed

Insights

Nano-insulin pumps significantly improve outcomes for children with diabetic ketoacidosis (DKA). This advanced technology reduces recovery time and hospital stays compared to traditional insulin pumps, offering a safer, more effective treatment for pediatric diabetes management.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Technology
  • Metabolic Disorders

Background:

  • Type 1 diabetes (T1D) in children necessitates insulin therapy due to absolute insulin deficiency.
  • Diabetic ketoacidosis (DKA) is a common, serious complication in pediatric T1D.
  • Traditional insulin pumps, while beneficial, pose risks of pain and infection in children.

Purpose of the Study:

  • To evaluate the efficacy and safety of nano-insulin pump infusion (NIP) versus traditional insulin pump (IP) in pediatric DKA patients.
  • To compare clinical indicators, recovery times, and complication rates between NIP and IP groups.

Main Methods:

  • A randomized controlled study involving 72 children diagnosed with DKA.
  • Participants were divided into two groups: traditional insulin pump (IP) and nano-insulin pump (NIP) infusion.
  • Key clinical parameters, including blood glucose, ketone levels, and venous pH, were monitored.

Main Results:

  • The NIP group showed greater reductions in fasting blood glucose (FBG) and postprandial blood glucose (PBG).
  • NIP significantly shortened recovery times for urine ketone, blood ketone, glucose, and venous pH compared to IP (P < 0.05).
  • The NIP group experienced shorter hospital stays, lower insulin dosage, and reduced incidence of hypoglycemia and infusion site infections (P < 0.05).

Conclusions:

  • Nano-insulin pump infusion is a highly effective treatment for children with DKA.
  • NIP offers rapid and significant improvements in glycemic control and ketone body levels.
  • This technology enhances patient safety by reducing complications and hospital resource utilization.

More Related Videos

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice10:43

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

28.4K
Effective Isolation of Functional Islets from Neonatal Mouse Pancreas07:04

Effective Isolation of Functional Islets from Neonatal Mouse Pancreas

Published on: January 6, 2017

10.5K

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
370
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
374
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
766
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.2K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
511